Life Sciences
The aim of the acquisitions is to accelerate the company's involvement in two major growth areas and improve patient care.
Sanofi invests in Zucara Therapeutics and MintNeuro raises $1.27 million in a funding round.
The collaboration aims to foster innovation, commercialization and adoption of AI in imaging.
HCA members will have access to and support for MGI's single cell and spatial omics technologies.
The company will use the funds to expand in Asian and U.S. markets, advance its AI algorithms and grow its workforce.
The aim of the alliance is to collect insights on patient outcomes and drug effectiveness with the Dario Connect platform.
The funding will support clinical trials for the company's NeuroHawk brain-scanning device.
The acquisition includes Jack's Canadian clinical assets, the authority to operate 16 medical clinics across 13 Canadian cities and the rights to operate clinics in Walmart stores in Canada.
The CRISPR therapy, HG202, was conceived using AI and machine learning and aims to treat individuals with neovascular age-related macular degeneration.
MedAware's AI-enabled platform allows pharmacists and clinical care personnel to intervene with medication dosages and therapy changes before potential harm occurs.